New Zealand markets closed

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
28.26+0.15 (+0.53%)
As of 10:05AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
1,134,834
1,134,834
42,832
619,728
975,040
Depreciation & amortisation
0
0
5,670
22,996
23,058
Stock-based compensation
2,357
2,357
2,170
2,443
5,428
Change in working capital
5,382
5,382
32,662
-16,322
75,966
Accounts payable
6,236
6,236
2,286
-4,586
-766
Other working capital
2,987,802
2,987,802
2,143,980
2,017,536
2,034,629
Other non-cash items
3,242,821
3,242,821
2,486,258
2,289,581
2,122,708
Net cash provided by operating activities
2,987,802
2,987,802
2,143,980
2,017,536
2,034,629
Cash flows from investing activities
Acquisitions, net
-12,542
-12,542
-9,896
-34,855
-40,155
Purchases of investments
-2,115,522
-2,115,522
-2,565,068
-3,593,656
-3,937,529
Sales/maturities of investments
25,831
25,831
1,545,543
1,776,308
1,203,280
Other investing activities
-14,438
-14,438
-
-18,600
-2,182,246
Net cash used for investing activities
-2,072,789
-2,072,789
-1,029,421
-1,870,280
-2,759,320
Cash flows from financing activities
Debt repayment
-1,350,000
-1,350,000
0
0
-11,210,396
Common stock issued
-
-
0
0
1,908,744
Common stock repurchased
-304,759
-304,759
0
0
0
Dividends paid
-358,327
-358,327
-333,322
-285,184
-397,843
Other financing activities
-485,668
-485,668
-611,534
-602,237
-704,363
Net cash used provided by (used for) financing activities
-2,148,754
-2,148,754
-944,856
385,112
1,487,172
Net change in cash
-1,233,741
-1,233,741
169,703
532,368
762,481
Cash at beginning of period
1,710,751
1,710,751
1,541,048
1,008,680
246,199
Cash at end of period
477,010
477,010
1,710,751
1,541,048
1,008,680
Free cash flow
Operating cash flow
2,987,802
2,987,802
2,143,980
2,017,536
2,034,629
Free cash flow
2,987,802
2,987,802
2,143,980
2,017,536
2,034,629